CHS Inc. (CHSCN) Stock Competitors & Peer Comparison
See (CHSCN) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHSCN | $24.89 | -0.52% | 312.4M | N/A | N/A | +7.39% |
| ADM | $82.08 | +3.92% | 38.8B | 23.45 | $3.43 | +2.57% |
| BG | $117.47 | +3.38% | 22.2B | 15.45 | $7.40 | +2.47% |
| TSN | $57.71 | +0.00% | 20.6B | 14.83 | $3.90 | +3.51% |
| AGRO | $10.49 | +4.90% | 5.8B | -34.43 | -$0.30 | +2.90% |
| CALM | $85.27 | -0.09% | 4.2B | 6.16 | $14.35 | +5.47% |
| IBA | $53.00 | -1.82% | 2.6B | 7.77 | $6.82 | +1.84% |
| FDP | $29.22 | +2.96% | 1.4B | 8.99 | $3.25 | +4.11% |
| DOLE | $14.20 | +1.28% | 1.4B | 12.11 | $1.18 | +2.38% |
| VITL | $12.78 | -1.39% | 554.9M | 12.45 | $1.04 | N/A |
Stock Comparison
CHSCN vs ADM Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, ADM has a market cap of 38.8B. Regarding current trading prices, CHSCN is priced at $24.89, while ADM trades at $82.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ADM's P/E ratio is 23.45. In terms of profitability, CHSCN's ROE is +0.05%, compared to ADM's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to ADM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check ADM's competition here
CHSCN vs BG Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, BG has a market cap of 22.2B. Regarding current trading prices, CHSCN is priced at $24.89, while BG trades at $117.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas BG's P/E ratio is 15.45. In terms of profitability, CHSCN's ROE is +0.05%, compared to BG's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to BG. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check BG's competition here
CHSCN vs TSN Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, TSN has a market cap of 20.6B. Regarding current trading prices, CHSCN is priced at $24.89, while TSN trades at $57.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas TSN's P/E ratio is 14.83. In terms of profitability, CHSCN's ROE is +0.05%, compared to TSN's ROE of +0.02%. Regarding short-term risk, CHSCN is less volatile compared to TSN. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check TSN's competition here
CHSCN vs AGRO Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, AGRO has a market cap of 5.8B. Regarding current trading prices, CHSCN is priced at $24.89, while AGRO trades at $10.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRO's P/E ratio is -34.43. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRO's ROE of +0.01%. Regarding short-term risk, CHSCN is less volatile compared to AGRO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRO's competition here
CHSCN vs CALM Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, CALM has a market cap of 4.2B. Regarding current trading prices, CHSCN is priced at $24.89, while CALM trades at $85.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CALM's P/E ratio is 6.16. In terms of profitability, CHSCN's ROE is +0.05%, compared to CALM's ROE of +0.26%. Regarding short-term risk, CHSCN is less volatile compared to CALM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CALM's competition here
CHSCN vs IBA Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, IBA has a market cap of 2.6B. Regarding current trading prices, CHSCN is priced at $24.89, while IBA trades at $53.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas IBA's P/E ratio is 7.77. In terms of profitability, CHSCN's ROE is +0.05%, compared to IBA's ROE of +0.12%. Regarding short-term risk, CHSCN is less volatile compared to IBA. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check IBA's competition here
CHSCN vs FDP Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, FDP has a market cap of 1.4B. Regarding current trading prices, CHSCN is priced at $24.89, while FDP trades at $29.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas FDP's P/E ratio is 8.99. In terms of profitability, CHSCN's ROE is +0.05%, compared to FDP's ROE of +0.03%. Regarding short-term risk, CHSCN is less volatile compared to FDP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check FDP's competition here
CHSCN vs DOLE Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, DOLE has a market cap of 1.4B. Regarding current trading prices, CHSCN is priced at $24.89, while DOLE trades at $14.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas DOLE's P/E ratio is 12.11. In terms of profitability, CHSCN's ROE is +0.05%, compared to DOLE's ROE of +0.03%. Regarding short-term risk, CHSCN is less volatile compared to DOLE. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check DOLE's competition here
CHSCN vs VITL Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, VITL has a market cap of 554.9M. Regarding current trading prices, CHSCN is priced at $24.89, while VITL trades at $12.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VITL's P/E ratio is 12.45. In terms of profitability, CHSCN's ROE is +0.05%, compared to VITL's ROE of +0.14%. Regarding short-term risk, CHSCN is less volatile compared to VITL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check VITL's competition here
CHSCN vs CVGW Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, CVGW has a market cap of 466.3M. Regarding current trading prices, CHSCN is priced at $24.89, while CVGW trades at $26.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CVGW's P/E ratio is 28.99. In terms of profitability, CHSCN's ROE is +0.05%, compared to CVGW's ROE of +0.08%. Regarding short-term risk, CHSCN is more volatile compared to CVGW. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CVGW's competition here
CHSCN vs LND Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, LND has a market cap of 356.6M. Regarding current trading prices, CHSCN is priced at $24.89, while LND trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LND's P/E ratio is -141.39. In terms of profitability, CHSCN's ROE is +0.05%, compared to LND's ROE of -0.02%. Regarding short-term risk, CHSCN is less volatile compared to LND. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LND's competition here
CHSCN vs CHSCO Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, CHSCO has a market cap of 311.7M. Regarding current trading prices, CHSCN is priced at $24.89, while CHSCO trades at $25.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCO's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCO's ROE of +0.05%. Regarding short-term risk, CHSCN is more volatile compared to CHSCO. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CHSCO's competition here
CHSCN vs CHSCM Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, CHSCM has a market cap of 309.7M. Regarding current trading prices, CHSCN is priced at $24.89, while CHSCM trades at $24.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCM's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCM's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to CHSCM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CHSCM's competition here
CHSCN vs CHSCP Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, CHSCP has a market cap of 309.3M. Regarding current trading prices, CHSCN is priced at $24.89, while CHSCP trades at $26.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCP's P/E ratio is 0.61. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCP's ROE of +0.05%. Regarding short-term risk, CHSCN is more volatile compared to CHSCP. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CHSCP's competition here
CHSCN vs ALCO Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, ALCO has a market cap of 305.3M. Regarding current trading prices, CHSCN is priced at $24.89, while ALCO trades at $41.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ALCO's P/E ratio is -13.91. In terms of profitability, CHSCN's ROE is +0.05%, compared to ALCO's ROE of -0.18%. Regarding short-term risk, CHSCN is less volatile compared to ALCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check ALCO's competition here
CHSCN vs AFRI Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, AFRI has a market cap of 285.5M. Regarding current trading prices, CHSCN is priced at $24.89, while AFRI trades at $10.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AFRI's P/E ratio is -23.53. In terms of profitability, CHSCN's ROE is +0.05%, compared to AFRI's ROE of +0.46%. Regarding short-term risk, CHSCN is less volatile compared to AFRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AFRI's competition here
CHSCN vs VFF Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, VFF has a market cap of 248.5M. Regarding current trading prices, CHSCN is priced at $24.89, while VFF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VFF's P/E ratio is 9.27. In terms of profitability, CHSCN's ROE is +0.05%, compared to VFF's ROE of +0.14%. Regarding short-term risk, CHSCN is less volatile compared to VFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check VFF's competition here
CHSCN vs LMNR Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, LMNR has a market cap of 239.7M. Regarding current trading prices, CHSCN is priced at $24.89, while LMNR trades at $13.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LMNR's P/E ratio is -15.78. In terms of profitability, CHSCN's ROE is +0.05%, compared to LMNR's ROE of -0.25%. Regarding short-term risk, CHSCN is less volatile compared to LMNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LMNR's competition here
CHSCN vs AGFS Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, AGFS has a market cap of 161.2M. Regarding current trading prices, CHSCN is priced at $24.89, while AGFS trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGFS's P/E ratio is -2.61. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGFS's ROE of -0.12%. Regarding short-term risk, CHSCN is less volatile compared to AGFS. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGFS's competition here
CHSCN vs AVX Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, AVX has a market cap of 40.4M. Regarding current trading prices, CHSCN is priced at $24.89, while AVX trades at $4.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AVX's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to AVX's ROE of -0.87%. Regarding short-term risk, CHSCN is less volatile compared to AVX. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AVX's competition here
CHSCN vs LOCL Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, LOCL has a market cap of 29.2M. Regarding current trading prices, CHSCN is priced at $24.89, while LOCL trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LOCL's P/E ratio is -0.34. In terms of profitability, CHSCN's ROE is +0.05%, compared to LOCL's ROE of +0.44%. Regarding short-term risk, CHSCN is less volatile compared to LOCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LOCL's competition here
CHSCN vs SDOT Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, SDOT has a market cap of 23.7M. Regarding current trading prices, CHSCN is priced at $24.89, while SDOT trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SDOT's P/E ratio is 0.53. In terms of profitability, CHSCN's ROE is +0.05%, compared to SDOT's ROE of +6.12%. Regarding short-term risk, CHSCN is less volatile compared to SDOT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check SDOT's competition here
CHSCN vs PME Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, PME has a market cap of 23.2M. Regarding current trading prices, CHSCN is priced at $24.89, while PME trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas PME's P/E ratio is 13.50. In terms of profitability, CHSCN's ROE is +0.05%, compared to PME's ROE of -0.03%. Regarding short-term risk, CHSCN is less volatile compared to PME. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check PME's competition here
CHSCN vs APPHW Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, APPHW has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $24.89, while APPHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPHW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to APPHW's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPHW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check APPHW's competition here
CHSCN vs APPH Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, APPH has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $24.89, while APPH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPH's P/E ratio is -0.14. In terms of profitability, CHSCN's ROE is +0.05%, compared to APPH's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPH. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check APPH's competition here
CHSCN vs AGRZ Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, AGRZ has a market cap of 9.3M. Regarding current trading prices, CHSCN is priced at $24.89, while AGRZ trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRZ's P/E ratio is 4.74. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRZ's ROE of +0.37%. Regarding short-term risk, CHSCN is less volatile compared to AGRZ. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRZ's competition here
CHSCN vs AQB Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, AQB has a market cap of 3.7M. Regarding current trading prices, CHSCN is priced at $24.89, while AQB trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AQB's P/E ratio is -0.20. In terms of profitability, CHSCN's ROE is +0.05%, compared to AQB's ROE of -3.68%. Regarding short-term risk, CHSCN is less volatile compared to AQB. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AQB's competition here
CHSCN vs KALWW Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, KALWW has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $24.89, while KALWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KALWW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to KALWW's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KALWW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check KALWW's competition here
CHSCN vs KAL Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, KAL has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $24.89, while KAL trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KAL's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.05%, compared to KAL's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KAL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check KAL's competition here
CHSCN vs AGRI Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, AGRI has a market cap of 1.9M. Regarding current trading prices, CHSCN is priced at $24.89, while AGRI trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRI's P/E ratio is 0.00. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRI's ROE of -0.92%. Regarding short-term risk, CHSCN is less volatile compared to AGRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRI's competition here
CHSCN vs EDBLW Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, EDBLW has a market cap of 1.6M. Regarding current trading prices, CHSCN is priced at $24.89, while EDBLW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBLW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to EDBLW's ROE of -1.39%. Regarding short-term risk, CHSCN is less volatile compared to EDBLW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check EDBLW's competition here
CHSCN vs AGRIW Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, AGRIW has a market cap of 66.2K. Regarding current trading prices, CHSCN is priced at $24.89, while AGRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRIW's P/E ratio is -0.00. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRIW's ROE of -0.87%. Regarding short-term risk, CHSCN is less volatile compared to AGRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRIW's competition here
CHSCN vs AAGRW Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, AAGRW has a market cap of 57.9K. Regarding current trading prices, CHSCN is priced at $24.89, while AAGRW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AAGRW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to AAGRW's ROE of +3.27%. Regarding short-term risk, CHSCN is less volatile compared to AAGRW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AAGRW's competition here
CHSCN vs EDBL Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, EDBL has a market cap of 27.5K. Regarding current trading prices, CHSCN is priced at $24.89, while EDBL trades at $4.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBL's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to EDBL's ROE of -1.39%. Regarding short-term risk, CHSCN is less volatile compared to EDBL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check EDBL's competition here
CHSCN vs LIDM Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, LIDM has a market cap of 0. Regarding current trading prices, CHSCN is priced at $24.89, while LIDM trades at $62.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LIDM's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to LIDM's ROE of N/A. Regarding short-term risk, CHSCN is more volatile compared to LIDM. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check LIDM's competition here
CHSCN vs OME Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, OME has a market cap of 0. Regarding current trading prices, CHSCN is priced at $24.89, while OME trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas OME's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to OME's ROE of +0.10%. Regarding short-term risk, CHSCN is more volatile compared to OME. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check OME's competition here
CHSCN vs LOCL-WT Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, LOCL-WT has a market cap of 0. Regarding current trading prices, CHSCN is priced at $24.89, while LOCL-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LOCL-WT's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to LOCL-WT's ROE of +0.44%. Regarding short-term risk, CHSCN is less volatile compared to LOCL-WT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LOCL-WT's competition here
CHSCN vs TSNU Comparison July 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.4M. In comparison, TSNU has a market cap of 0. Regarding current trading prices, CHSCN is priced at $24.89, while TSNU trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas TSNU's P/E ratio is 12.41. In terms of profitability, CHSCN's ROE is +0.05%, compared to TSNU's ROE of +0.02%. Regarding short-term risk, CHSCN is less volatile compared to TSNU. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check TSNU's competition here